StockNews.com lowered shares of Theravance Biopharma (NASDAQ:TBPH – Free Report) from a buy rating to a hold rating in a report issued on Tuesday morning. Several other equities analysts have also commented on TBPH. HC Wainwright reaffirmed a buy rating and issued a $20.00 price objective on shares of Theravance Biopharma in a research report […]
Teacher Retirement System of Texas reduced its holdings in shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 28.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 10,100 shares of the biopharmaceutical company’s stock after selling 3,969 shares […]
StockNews.com upgraded shares of Theravance Biopharma (NASDAQ:TBPH – Free Report) from a hold rating to a buy rating in a research report report published on Monday. Several other equities research analysts also recently commented on the stock. BTIG Research began coverage on shares of Theravance Biopharma in a research report on Friday, April 12th. They […]
Theravance Biopharma, Inc. (NASDAQ:TBPH – Get Free Report) passed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $10.26 and traded as high as $11.26. Theravance Biopharma shares last traded at $11.24, with a volume of 350,184 shares traded. Analyst Upgrades and Downgrades Separately, StockNews.com initiated […]
Theravance Biopharma, Inc. (NASDAQ:TBPH – Get Free Report) SVP Richard A. Graham sold 2,482 shares of Theravance Biopharma stock in a transaction that occurred on Tuesday, November 14th. The shares were sold at an average price of $10.22, for a total transaction of $25,366.04. Following the sale, the senior vice president now directly owns 346,839 […]